CDE Detailed Report

Disease: Stroke
Subdomain Name: Drugs
CRF: Thrombolytic

Displaying 1 - 25 of 25
CDE ID CDE Name Variable Name Definition Short Description Question Text Permissible Values Description Data Type Disease Specific Instructions Disease Specific Reference Population Classification (e.g., Core) Version Number Version Date CRF Name (CRF Module / Guidance) Subdomain Name Domain Name Size Input Restrictions Min Value Max Value Measurement Type External Id Loinc External Id Snomed External Id caDSR External Id CDISC
C60361 IV thrombolytic agent type IVThrombolyticAgntTyp Type of IV thrombolytic agent given to the participant Type of IV thrombolytic agent given to the participant Type of IV thrombolytic agent used Alteplase;Tenecteplase;Other, specify Alteplase;Tenecteplase;Other, specify Alphanumeric

Choose all that apply.

No references available Adult;Pediatric Supplemental 1 6/10/2024 10:12 AM Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data

Multiple Pre-Defined Values Selected

C60362 IV thrombolytic agent type other text IVThrombolyticAgntTypOTH The free-text field related to 'IV thrombolytic agent type' specifying other text. The free-text field related to 'IV thrombolytic agent type' specifying other text. Other, specify Alphanumeric

The free-text field related to 'IV thrombolytic agent type' specifying other text.

No references available Adult;Pediatric Supplemental 1 6/10/2024 10:24 AM Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data 255

Free-Form Entry

C60363 IV thrombolytic agent not started reason IVThrombolyticAgntNotStartRsn If NO Intravenous thrombolytic agent was initiated, documents reasons in the medical record for why no IV thrombolytic agent was started for the participant at the current hospital. If NO Intravenous thrombolytic agent was initiated, documents reasons in the medical record for why no IV thrombolytic agent was started for the participant at the current hospital. Reason(s) no IV thrombolytic agent started at the current hospital Active internal bleeding (<22 days);CT findings (ICH, SAH, or major infarct signs);History of intracranial hemorrhage or brain aneurysm or vascular malformation or brain tumor;Platelets <100,000, PTT> 40 sec after heparin use, or PT > 15 or INR > 1.7, or known bleeding diathesis;Recent intracranial or spinal surgery, head trauma, or stroke (<3 mo.);Recent surgery/trauma (<15 days);SBP > 185 or DBP > 110 mmHg despite treatment;Seizure at onset;Suspicion of subarachnoid hemorrhage;Subacute Bacterial Endocarditis (SBE);Advanced age;Care-team unable to determine eligibility;Glucose < 50 or > 400 mg/dl;Increased risk of bleeding due to Acute pericarditis, SBE, Hemostatic defects, Diabetic hemorrhagic retinopathy, Septic thrombophlebitis/occluded AV cannula, or currently receiving oral anticoagulants;IV or IA thrombolytic agent given at outside hospital;Left heart thrombus;Life expectancy < 1 year or severe co-morbid illness or CMO on admission;Pregnancy;Participant/Family refused;Rapid improvement;Stroke severity nondisabling;Stroke severity - Too severe (e.g., NIHSS >22);Age > 80;Prior Stroke and Diabetes;Any anticoagulant use prior to admission (even if INR < 1.7);NIHSS > 25;CT findings of >1/3 MCA;Delay in Participant Arrival;Delay in Stroke diagnosis;In-hospital Time Delay;No IV access;MRI not feasible;CTP not feasible;Other, specify Active internal bleeding (<22 days);CT findings (ICH, SAH, or major infarct signs);History of intracranial hemorrhage or brain aneurysm or vascular malformation or brain tumor;Platelets <100,000, PTT> 40 sec after heparin use, or PT > 15 or INR > 1.7, or known bleeding diathesis;Recent intracranial or spinal surgery, head trauma, or stroke (<3 mo.);Recent surgery/trauma (<15 days);SBP > 185 or DBP > 110 mmHg despite treatment;Seizure at onset;Suspicion of subarachnoid hemorrhage;Subacute Bacterial Endocarditis (SBE);Advanced age;Care-team unable to determine eligibility;Glucose < 50 or > 400 mg/dl;Increased risk of bleeding due to Acute pericarditis, SBE, Hemostatic defects, Diabetic hemorrhagic retinopathy, Septic thrombophlebitis/occluded AV cannula, or currently receiving oral anticoagulants;IV or IA thrombolytic agent given at outside hospital;Left heart thrombus;Life expectancy < 1 year or severe co-morbid illness or CMO on admission;Pregnancy;Participant/Family refused;Rapid improvement;Stroke severity nondisabling;Stroke severity - Too severe (e.g., NIHSS >22);Age > 80;Prior Stroke and Diabetes;Any anticoagulant use prior to admission (even if INR < 1.7);NIHSS > 25;CT findings of >1/3 MCA;Delay in Participant Arrival;Delay in Stroke diagnosis;In-hospital Time Delay;No IV access;MRI not feasible;CTP not feasible;Other, specify Alphanumeric

Choose all that apply.

American Heart/American Stroke Association. (2018). Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (? 2018, American Heart/American Stroke Association). Available at: https://www.heart.org/-/media/files/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/stroke-fact-sheet_-final_ucm_501842.pdf?la=en; Paul Coverdell National Acute Stroke Registry Adult;Pediatric Supplemental 1 6/10/2024 10:27 AM Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data

Multiple Pre-Defined Values Selected

C60364 IV thrombolytic agent not started other text IVThrombolyticAgntNotStartOTH The free-text field related to 'IV thrombolytic agent not started reason' specifying other text. If NO Intravenous thrombolytic agent was initiated, documents reasons in the medical record for why no IV thrombolytic agent was started for the participant at the current hospital. The free-text field related to 'IV thrombolytic agent not started reason' specifying other text. If NO Intravenous thrombolytic agent was initiated, documents reasons in the medical record for why no IV thrombolytic agent was started for the participant a Other, specify Alphanumeric

Choose all that apply.

American Heart/American Stroke Association. (2018). Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (? 2018, American Heart/American Stroke Association). Available at: https://www.heart.org/-/media/files/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/stroke-fact-sheet_-final_ucm_501842.pdf?la=en; Paul Coverdell National Acute Stroke Registry Adult;Pediatric Supplemental 1 6/10/2024 1:38 PM Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data 255

Free-Form Entry

C60365 IV thrombolytic agent not started MRI selection treatment beyond 4.5 hour reason IVTANtStMRITrtSctByd4HlfHrRsn If NO Intravenous thrombolytic agent was initiated for the participant/subject treated using MRI imaging selection beyond 4.5 hours, documents reasons in the medical record for why no IV thrombolytic agent was started for the participant at the current hospital. If NO Intravenous thrombolytic agent was initiated for the participant/subject treated using MRI imaging selection beyond 4.5 hours, documents reasons in the medical record for why no IV thrombolytic agent was started for the participant at the current ho Other reasons thrombolytic agent is not started for patients treated using MRI imaging selection beyond 4.5 hours Treatment cannot be started within 4.5 hours of symptom recognition;Age > 80;Parenchymal hyperintensity visible on FLAIR;NIHSS > 25;CT findings of >1/3 MCA or >50% of ACA or PCA territories, or > 100ml;Any MRI findings indicative of a high risk of SICH Treatment cannot be started within 4.5 hours of symptom recognition;Age > 80;Parenchymal hyperintensity visible on FLAIR;NIHSS > 25;CT findings of >1/3 MCA or >50% of ACA or PCA territories, or > 100ml;Any MRI findings indicative of a high risk of SICH Alphanumeric

Choose all that apply.

No references available Adult;Pediatric Exploratory 1 6/10/2024 1:42 PM Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data

Multiple Pre-Defined Values Selected

C60366 IV thrombolytic agent at another hospital indicator IVThrmblAgntAnotherHospitalInd Indicator of whether IV thrombolytic agent was initiated for the participant at an outside hospital Indicator of whether IV thrombolytic agent was initiated for the participant at an outside hospital Was IV thrombolytic agent initiated at an outside hospital? Yes;No;Unknown Yes;No;Unknown Alphanumeric

Choose one.

American Heart/American Stroke Association. (2018). Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (? 2018, American Heart/American Stroke Association). Available at: https://www.heart.org/-/media/files/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/stroke-fact-sheet_-final_ucm_501842.pdf?la=en; Paul Coverdell National Acute Stroke Registry Adult;Pediatric Supplemental 1 6/10/2024 1:45 PM Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C14399 IV tPA not started reason IVtPANotStartRsn If NO Intravenous Tissue Plasminogen Activator (IV tPA) was initiated, documents reasons in the medical record for why no IV tPA was started for the participant/subject at your hospital. Were one or more of the following reasons for not administering IV thrombolytic therapy at this hospital explicitly documented by a physician, advance practice nurse, or physician assistant's notes in the medical record? If NO Intravenous Tissue Plasminogen Activator (IV tPA) was initiated, documents reasons in the medical record for why no IV tPA was started for the participant/subject at your hospital. Were one or more of the following reasons for not administering IV thrombolytic therapy at this hospital explicitly documented by a physician, advance practice nurse, or physician assistant's notes in the medical record Reason(s) no IV tPA started at this hospital Active internal bleeding (<22 days);CT findings (ICH, SAH, or major infarct signs);History of intracranial hemorrhage or brain aneurysm or vascular malformation or brain tumor;Platelets <100,000, PTT> 40 sec after heparin use, or PT > 15 or INR > 1.7, or known bleeding diathesis;Recent intracranial or spinal surgery, head trauma, or stroke (<3 mo.);Recent surgery/trauma (<15 days);SBP > 185 or DBP > 110 mmHg despite treatment;Seizure at onset;Suspicion of subarachnoid hemorrhage;Subacute Bacterial Endocarditis (SBE);Advanced age;Care-team unable to determine eligibility;Glucose < 50 or > 400 mg/dl;Increased risk of bleeding due to Acute pericarditis, SBE, Hemostatic defects, Diabetic hemorrhagic retinopathy, Septic thrombophlebitis/occluded AV cannula, or currently receiving oral anticoagulants;IV or IA tPA given at outside hospital;Left heart thrombus;Life expectancy < 1 year or severe co-morbid illness or CMO on admission;Pregnancy;Patient/Family refused;Rapid improvement;Stroke severity - Too severe (e.g., NIHSS >22);Age > 80;Prior Stroke and Diabetes;Any anticoagulant use prior to admission (even if INR < 1.7);NIHSS > 25;CT findings of >1/3 MCA;Delay in Patient Arrival;Delay in Stroke diagnosis;In-hospital Time Delay;No IV access;Other, specify;Stroke severity nondisabling;MRI not feasible;CTP not feasible Active internal bleeding (<22 days);CT findings (ICH, SAH, or major infarct signs);History of intracranial hemorrhage or brain aneurysm or vascular malformation or brain tumor;Platelets <100,000, PTT> 40 sec after heparin use, or PT > 15 or INR > 1.7, or known bleeding diathesis;Recent intracranial or spinal surgery, head trauma, or stroke (<3 mo.);Recent surgery/trauma (<15 days);SBP > 185 or DBP > 110 mmHg despite treatment;Seizure at onset;Suspicion of subarachnoid hemorrhage;Subacute Bacterial Endocarditis (SBE);Advanced age;Care-team unable to determine eligibility;Glucose < 50 or > 400 mg/dl;Increased risk of bleeding due to Acute pericarditis, SBE, Hemostatic defects, Diabetic hemorrhagic retinopathy, Septic thrombophlebitis/occluded AV cannula, or currently receiving oral anticoagulants;IV or IA tPA given at outside hospital;Left heart thrombus;Life expectancy < 1 year or severe co-morbid illness or CMO on admission;Pregnancy;Patient/Family refused;Rapid improvement;Stroke severity - Too severe (e.g., NIHSS >22);Age > 80;Prior Stroke and Diabetes;Any anticoagulant use prior to admission (even if INR < 1.7);NIHSS > 25;CT findings of >1/3 MCA;Delay in Patient Arrival;Delay in Stroke diagnosis;In-hospital Time Delay;No IV access;Other, specify;Stroke severity nondisabling;MRI not feasible;CTP not feasible Alphanumeric

Choose all that apply.

American Heart/American Stroke Association. (2018). Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (&copy; 2018, American Heart/American Stroke Association). Available at: https://www.heart.org/-/media/files/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/stroke-fact-sheet_-final_ucm_501842.pdf?la=en; Paul Coverdell National Acute Stroke Registry Adult;Pediatric Supplemental 3.00 2013-06-21 00:00:00.0 Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data

Multiple Pre-Defined Values Selected

C14400 IV tPA at another hospital indicator IVtPAAnotherHospitalInd Indicates whether IV tPA was initiated for the participant/subject at an outside hospital Indicates whether IV tPA was initiated for the participant/subject at an outside hospital Was IV tPA initiated at an outside hospital Yes;No;Unknown Yes;No;Unknown Alphanumeric

Choose one.

American Heart/American Stroke Association. (2018). Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (&copy; 2018, American Heart/American Stroke Association). Available at: https://www.heart.org/-/media/files/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/stroke-fact-sheet_-final_ucm_501842.pdf?la=en; Paul Coverdell National Acute Stroke Registry Adult;Pediatric Supplemental 3.00 2013-06-21 00:00:00.0 Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C18927 IV tPA not started other text IVtPANotStartOTH The free-text field related to 'IV tPA not started reason' specifying other text. If NO Intravenous Tissue Plasminogen Activator (IV tPA) was initiated, documents reasons in the medical record for why no IV tPA was started for the participant/subject at your hospital. Were one or more of the following reasons for not administering IV thrombolytic therapy at this hospital explicitly documented by a physician, advance practice nurse, or physician assistant's notes in the medical record? The free-text field related to 'IV tPA not started other text' specifying other text. If NO Intravenous Tissue Plasminogen Activator initiated, documents reasons in the medical record for why no IV tPA was started Other, specify Alphanumeric

Choose all that apply.

American Heart/American Stroke Association. (2018). Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (&copy; 2018, American Heart/American Stroke Association). Available at: https://www.heart.org/-/media/files/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/stroke-fact-sheet_-final_ucm_501842.pdf?la=en; Paul Coverdell National Acute Stroke Registry Adult;Pediatric Supplemental 3.00 2013-06-21 00:00:00.0 Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data 4000

Free-Form Entry

C58852 IV tPA not started MRI selection treatment beyond 4.5 hour reason IVtPANtStMRITrtSctByd4HlfHrRsn If NO Intravenous Tissue Plasminogen Activator (IV tPA) was initiated for the participant/subject treated using MRI imaging selection beyond 4.5 hours, documents reasons in the medical record for why no IV tPA was started for the participant/subject at your hospital. Were one or more of the following reasons for not administering IV thrombolytic therapy at this hospital explicitly documented by a physician, advance practice nurse, or physician assistant's notes in the medical record? If NO Intravenous Tissue Plasminogen Activator (IV tPA) was initiated for the participant/subject treated using MRI imaging selection beyond 4.5 hours, documents reasons in the medical record for why no IV tPA was started for the participant/subject at your hospital. Were one or more of the following reasons for not administering IV thrombolytic therapy at this hospital explicitly documented by a physician, advance practice nurse, or physician assistant's notes in the medical record Other reasons tPA is not started for patients treated using MRI imaging selection beyond 4.5 hours Treatment cannot be started within 4.5 hours of symptom recognition;Age > 80;Parenchymal hyperintensity visible on FLAIR;NIHSS > 25;CT findings of >1/3 MCA or >50% of ACA or PCA territories, or > 100ml;Any MRI findings indicative of a high risk of SICH Treatment cannot be started within 4.5 hours of symptom recognition;Age > 80;Parenchymal hyperintensity visible on FLAIR;NIHSS > 25;CT findings of >1/3 MCA or >50% of ACA or PCA territories, or > 100ml;Any MRI findings indicative of a high risk of SICH Alphanumeric

Choose all that apply.

No references available Adult;Pediatric Exploratory 1.00 2020-05-18 08:48:38.0 Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data

Multiple Pre-Defined Values Selected

C60360 IV thrombolytic agent total dose IVThrombolyticAgntTtlDose Dose of IV thrombolytic agent, in mg, given to the participant Dose of IV thrombolytic agent, in mg, given to the participant Total IV thrombolytic agent dose given Numeric Values

Record the numeric dose of thrombolytic agent in mg. It is important to consult these other data elements when calculating the IV thrombolytic agent dose: Stroke Onset Time/ Time Participant Last Seen Well and Body Weight in kilograms.

No references available Adult;Pediatric Supplemental 1 6/10/2024 10:08 AM Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data

Free-Form Entry

0 300 milligram
C58857 Angiographic image last date and time AngiographicImageLstDateTime Date (and time, if applicable and known) of last angiographic image for the participant/subject Date (and time, if applicable and known) of last angiographic image for the participant/subject Date and Time of last angiographic image or the end time for mechanical/pharmacologic intervention Date or Date & Time

If time of the last mechanical or pharmacological intervention not available, use the time on the last angiographic image.

Record the date/time according to the ISO 8601, the International Standard for the representation of dates and times (http://www.iso.org/iso/home.html). The date/time should be recorded to the level of granularity known (e.g., year, year and month, complete date plus hours and minutes, etc.).

No references available Adult;Pediatric Supplemental 1.00 2020-05-18 09:09:50.0 Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data

Free-Form Entry

C14408 Intra-sinus procedure type IntrasinProcedTyp If intra-sinus (i.e., for cerebral venous thrombosis) intervention was received, specifies the type of intra-sinus procedure performed on the participant/subject at this hospital If intra-sinus (i.e., for cerebral venous thrombosis) intervention was received, specifies the type of intra-sinus procedure performed on the participant/subject at this hospital Type of intra-sinus procedure Pharmacological;Mechanical;Both Pharmacological;Mechanical;Both Alphanumeric

Choose one.

No references available Adult;Pediatric Supplemental 3.00 2013-06-21 00:00:00.0 Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C14409 Intra-sinus intervention groin puncture date and time IntrasinIntrvntGrnPuncDateTime Date (and time, if applicable and known) of groin puncture on the participant/ subject for intra-sinus intervention Date (and time, if applicable and known) of groin puncture on the participant/ subject for intra-sinus intervention Date and Time of groin puncture for intra-sinus procedure Date or Date & Time

Record the date/time according to the ISO 8601, the International Standard for the representation of dates and times (http://www.iso.org/iso/home.html). The date/time should be recorded to the level of granularity known (e.g., year, year and month, complete date plus hours and minutes, etc.).

No references available Adult;Pediatric Supplemental 3.00 2013-06-21 00:00:00.0 Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data

Free-Form Entry

C14410 Intra-sinus intervention initiated date and time IntrasinIntrvntInitiatDateTime Date (and time, if applicable and known) intra-sinus (IS) intervention (i.e., for cerebral venous thrombosis) was initiated at this hospital or ED Date (and time, if applicable and known) intra-sinus (IS) intervention (i.e., for cerebral venous thrombosis) was initiated at this hospital or ED Date and Time intra-sinus intervention initiated Date or Date & Time

The start time for IS therapy should be either the date and time on the angio showing evidence of treatment, or the start time of the infusion or mechanical deployment if the angio time is not available.

Record the date/time according to the ISO 8601, the International Standard for the representation of dates and times (http://www.iso.org/iso/home.html). The date/time should be recorded to the level of granularity known (e.g., year, year and month, complete date plus hours and minutes, etc.).

No references available Adult;Pediatric Supplemental 3.00 2013-06-21 00:00:00.0 Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data

Free-Form Entry

C06005 Data collected date and time DataCollDateTime Date (and time, if applicable and known) the data were collected. This may be the date/time a particular examination or procedure was performed Date (and time, if applicable and known) the data were collected. This may be the date/time a particular examination or procedure was performe Date information collected Date or Date & Time

Record the date/time according to the ISO 8601, the International Standard for the representation of dates and times (http://www.iso.org/iso/home.html). The date/time should be recorded to the level of granularity known (e.g., year, year and month, complete date plus hours and minutes, etc.).

No references available Adult;Pediatric Supplemental 3.00 2013-07-24 21:00:23.88 Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data

Free-Form Entry

C14411 Investigational or experimental protocol for thrombolysis indicator InvestExpProtThrombolysInd Whether medical records suggest some kind of investigational thrombolytic protocol was used during provision of care Whether medical records suggest some kind of investigational thrombolytic protocol was used during provision of care Do the medical records suggest any type of investigational or experimental protocol for thrombolysis was used during provision of care Yes;No;Unknown Yes;No;Unknown Alphanumeric

Choose one. If yes, explain the protocol used.
If investigational or experimental protocol was used there should be a signed IRB consent in the medical record.

American Heart/American Stroke Association. (2018). Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (&copy; 2018, American Heart/American Stroke Association). Available at: https://www.heart.org/-/media/files/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/stroke-fact-sheet_-final_ucm_501842.pdf?la=en; Paul Coverdell National Acute Stroke Registry Adult;Pediatric Supplemental 3.00 2013-06-21 00:00:00.0 Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C14401 Intra-arterial (IA) procedure initiated indicator IAProcInitInd Indicates whether an Intra-arterial (IA) procedure was initiated for participant/ subject at this hospital Indicates whether an Intra-arterial (IA) procedure was initiated for participant/ subject at this hospita Was an IA procedure initiated at this hospital Yes;No;Unknown Yes;No;Unknown Alphanumeric

Choose one.

Endovascular procedures include mechanical thrombectomy and all uses of intra-arterial thrombolytic therapy. Mechanical thrombectomy may be used alone or in conjunction with intra-arterial thrombolytic therapy.

American Heart/American Stroke Association. (2018). Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (&copy; 2018, American Heart/American Stroke Association). Available at: https://www.heart.org/-/media/files/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/stroke-fact-sheet_-final_ucm_501842.pdf?la=en; Paul Coverdell National Acute Stroke Registry Adult;Pediatric Supplemental-Highly Recommended 3.00 2013-06-21 00:00:00.0 Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C58579 Investigational or experimental protocol for thrombolysis text InvestExpProtThrombolysTxt Free-text field to specify what type of investigational thrombolytic protocol was used during provision of care Free-text field to specify what type of investigational thrombolytic protocol was used during provision of care If YES, explain the protocol used Alphanumeric American Heart/American Stroke Association. (2018). Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (&copy; 2018, American Heart/American Stroke Association). Available at: https://www.heart.org/-/media/files/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/stroke-fact-sheet_-final_ucm_501842.pdf?la=en; Paul Coverdell National Acute Stroke Registry Adult;Pediatric Supplemental 3.00 2013-06-21 00:00:00.0 Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data 255

Free-Form Entry

C14402 Intra-arterial (IA) procedure type IAProcTyp If intra-arterial (IA) procedure was initiated, describes the type of intra-arterial (IA) procedure performed on participant/ subject at this hospital If intra-arterial (IA) procedure was initiated, describes the type of intra-arterial (IA) procedure performed on participant/ subject at this hospital Type of IA procedure Pharmacological;Mechanical;Both Pharmacological;Mechanical;Both Alphanumeric

Choose one.

No references available Adult;Pediatric Supplemental-Highly Recommended 3.00 2013-06-21 00:00:00.0 Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C14403 Intra-arterial (IA) procedure groin puncture date and time IAProcGroinPuncDateTime Date (and time, if applicable and known) of groin puncture on the participant/ subject for the intra-arterial (IA) procedure Date (and time, if applicable and known) of groin puncture on the participant/ subject for the intra-arterial (IA) procedure Date and Time of groin puncture for IA procedure Date or Date & Time

Record the date/time according to the ISO 8601, the International Standard for the representation of dates and times (http://www.iso.org/iso/home.html). The date/time should be recorded to the level of granularity known (e.g., year, year and month, complete date plus hours and minutes, etc.).

No references available Adult;Pediatric Supplemental 3.00 2013-06-21 00:00:00.0 Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data

Free-Form Entry

C14404 Intra-arterial (IA) catheter-based reperfusion initiated date and time IACathBasdReperfsInitDateTime Date (and time, if applicable and known) of last intra-arterial (IA) catheter-based reperfusion initiated for the participant/ subject at this hospital or ED Date (and time, if applicable and known) of last intra-arterial (IA) catheter-based reperfusion initiated for the participant/ subject at this hospital or ED Date and Time IA catheter-based reperfusion initiated Date or Date & Time

The start time for endovascular reperfusion therapy should be either the date and time on the angio showing evidence of treatment, or the start time of the infusion or mechanical deployment if the angio time is not available.

Record the date/time according to the ISO 8601, the International Standard for the representation of dates and times (http://www.iso.org/iso/home.html). The date/time should be recorded to the level of granularity known (e.g., year, year and month, complete date plus hours and minutes, etc.).

American Heart/American Stroke Association. (2018). Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (&copy; 2018, American Heart/American Stroke Association). Available at: https://www.heart.org/-/media/files/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/stroke-fact-sheet_-final_ucm_501842.pdf?la=en; Paul Coverdell National Acute Stroke Registry Adult;Pediatric Supplemental 3.00 2013-06-21 00:00:00.0 Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data

Free-Form Entry

C14405 Intervention mechanical or pharmacological end time IntrvntMechnPharmacEndTime The end time for mechanical, pharmacologic intervention for the participant/subject The end time for mechanical, pharmacologic intervention for the participant/subject Date and Time of last angiographic image or the end time for mechanical/pharmacologic intervention Date or Date & Time

If time of the last mechanical or pharmacological intervention not available, use the time on the last angiographic image.

Record the date/time according to the ISO 8601, the International Standard for the representation of dates and times (http://www.iso.org/iso/home.html). The date/time should be recorded to the level of granularity known (e.g., year, year and month, complete date plus hours and minutes, etc.).

No references available Adult;Pediatric Supplemental 3.00 2013-06-21 00:00:00.0 Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data

Free-Form Entry

C14406 Intra-arterial (IA) catheter-based reperfusion other hospital indicator IACathBasdReperfsnOthHospInd Indicates whether intra-arterial (IA) catheter-based reperfusion was initiated for the participant/subject at an outside hospital Indicates whether intra-arterial (IA) catheter-based reperfusion was initiated for the participant/subject at an outside hospital Was IA catheter-based reperfusion initiated at an outside hospital Yes;No;Unknown Yes;No;Unknown Alphanumeric

Choose one.

American Heart/American Stroke Association. (2018). Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (&copy; 2018, American Heart/American Stroke Association). Available at: https://www.heart.org/-/media/files/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/stroke-fact-sheet_-final_ucm_501842.pdf?la=en; Paul Coverdell National Acute Stroke Registry Adult;Pediatric Supplemental 3.00 2013-06-21 00:00:00.0 Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

C14407 Intra-sinus intervention indicator IntrasinIntrvntInd Indicates whether the participant/subject received any intra-sinus (i.e., for cerebral venous thrombosis) intervention Indicates whether the participant/subject received any intra-sinus (i.e., for cerebral venous thrombosis) intervention Was an intra-sinus intervention performed Yes;No;Unknown Yes;No;Unknown Alphanumeric

Choose one.
Relevant to venous sinus and their large draining veins

No references available Adult;Pediatric Supplemental 3.00 2013-06-21 00:00:00.0 Thrombolytic/Reperfusion Therapies Drugs Treatment/Intervention Data

Single Pre-Defined Value Selected

CSV